HLA-Matched Unrelated Donors for Patients with Sickle Cell Disease: Results of International Donor Searches.

• Patients with sickle cell disease (SCD) belong to ethnic groups underrepresented in donor registries. • We assessed chances of finding a matched unrelated donor by geographical origin. • Brazilian patients showed a greater genetic admixture than European Society for Blood and Marrow Transplantation patients. • However, chances of having a potential allelic matched unrelated donor were equal in the 2 groups (47%). • Further strategies to improve donor representativity are warranted in the SCD setting. Sickle cell disease (SCD) is the most common inherited hemoglobinopathy. Hematopoietic stem cell transplantation (HCT) is the sole curative therapy for SCD, but few patients will have a matched sibling donor. Patients with SCD are mostly of African origin and thus are less likely to find a matched unrelated donor in international registries. Using HaploStats, we estimated HLA haplotypes for 185 patients with SCD (116 from a Brazilian center and 69 from European Society for Blood and Marrow Transplantation [EBMT] centers) and classified the ethnic origin of haplotypes. Then we assessed the probability of finding an HLA-matched unrelated adult donor (MUD), considering loci A, B, and DRB1 (6/6), in international registries. Most haplotypes were African, but Brazilians showed a greater ethnic admixture than EBMT patients. Nevertheless, the chance of finding at least one 6/6 potential allelic donor was 47% for both groups. Most potential allelic donors were from the US National Marrow Donor Program registry and from the Brazilian REDOME donor registry. Although the probability of finding a donor is higher than previously reported, strategies are needed to improve ethnic diversity in registries. Moreover, predicting the likelihood of having an MUD might influence SCD management. [ABSTRACT FROM AUTHOR]